New Trends in Reimbursement Protocols, Health Quality Metrics, and Device Accuracy for Sensor-Based Glycemic Monitoring in the Managed Care Pharmacy Setting

View Symposium


Jointly provided by Postgraduate Institute for Medicine and CMEducation Resources

This activity is supported by an independent educational grant from Abbott Diabetes Care

Release date: October 16, 2023
Expiration Date: October 16, 2025
Estimated time to complete activity: 1.5 hours
For more information: www.pimed.com

Target Audience

This activity is intended for pharmacists, physicians, nurse practitioners and other healthcare professionals engaged in the care of patients with diabetes in the managed care, primary care, hospital and related settings.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Outline and discuss the evidentiary basis for senor/patch-based CGM technologies, and how to best Implement CGM-based technologies into their overall diabetes care plans for persons with diabetes within the managed care environment.
  • Discuss new developments in CMS (Medicare and Medicaid) reimbursement for persons on insulin therapy.
  • Better understand new technological advances in CGM devices with focus on AGP and Glucose Pattern Insight Reports.
  • Analyze the rationale and evidence for pharmacists recommending and facilitating adoption of technology-centric CGM monitoring and treatment plans using patch-and-reader-based technologies in the managed care setting.

Faculty

Diana Isaacs, PharmD, BCPS, BC-ADM, CDE – Program Chair
Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Cleveland Clinic Endocrinology and Metabolist Institute
Cleveland, OH

Eugene Wright, MD
Consulting Associate, Departments of Medicine
Duke University Medical Center
Durham, NC
Inaugural Chair, ADA Primary Care Interest Group
Medical Director for Performance Improvement
Charlotte Area Health Education Center
Charlotte, NC

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP
Professor of Pharmacy Practice
Clinical Pharmacist
Well Life Massachusetts College of Pharmacy and Heath Sciences
Boston, MA

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Diana Isaacs, PharmD, BCPS, BC-ADM, CDE – Program Chair
Speaker’s Bureau/Honoraria for Non-CME: Abbot, Dexcom, Novo Nordisk, Lilly, Cequr, Provention Bio, Tandem, Ascensia
Consultant/Advisory Board: Sanofi, Medtronic

Eugene Wright, MD
Speaker’s Bureau/Honoraria for Non-CME: Abbo` Diabetes Care, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Lilly, Renalytix
Consultant/Advisory Board: Abbott Diabetes Care, Bayer, Boehringer Ingelheim, Embecta, GlaxoSmithKline, Lilly, Medtronic, Renalytix, Sanofi

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP
Speaker’s Bureau/Honoraria for Non-CME: NovoNordisk, Lilly, Xeris, CeQur, Abbott Diabetes

The PIM planners and others have nothing to disclose. The CMEducation Resources planners and others have nothing to disclose.

Method of Participation and Request for Credit

In order to obtain your CME/CE certificate, please follow the steps below at the conclusion of the activity:

  1. Go to www.cmeuniversity.com
  2. Login or Create a New Account (will take less than 1 minute)
    1. If you receive a message when creating a new account that “the email you entered is already in use”, please click theForgot my Username or Passwordlink to have your Username and Password sent to you via email
    2. After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
  3. Type in 18197 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
  4. Click on the activity title when it appears
  5. Choose the type of credit you desire
  6. Complete the online assessment
  7. Receive an immediate CME/CE Certificate to download and/or print for your files

For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor. Pharmacists have up to thirty (30) days to complete the evaluation and claim credit. Please check your NABP account within thirty (30) days to make sure the credit has posted.

If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.

For Pharmacists: Upon receipt of the completed activity evaluation form, you will receive an email from CEcertificate@pimed.com within three weeks with a link and directions to submit your credit to the NABP CPE Monitor Service. 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CMEducation Resources, LLC.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Physician Continuing Medical Education

The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008162-9999-23-335-L01-P)
Type of Activity: Knowledge

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development.  The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Hardware and Software Requirements
To participate in this program, viewers must have a PC or Apple computer that has active, ongoing internet access for the duration of the program. An email address is required for registration, completion of evaluation, and access to CE/CME certificate.

View Symposium